NOS3 and glomerulosclerosis: Similar to erlotinib inhibition of EGFR, homozygous waved 2 mice crossed to eNOS–/–db/db mice exhibited decreased gain of body weight, lower fasting blood glucose, preserved pancreatic islet insulin levels, less islet macrophage infiltration, and less glomerulosclerosis.